Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women

Abstract

Background/Objectives:

The objective of this study was to evaluate the impact of three specific ruminant (R) milk fats resulting from modification of the cow's diet on cardiovascular risk factors in healthy volunteers. R-milk fats were characterized by increased content in total trans fatty acids (R-TFAs) and parallel decrease in saturated fatty acids (SFAs).

Subjects/Methods:

A total of 111 healthy, normolipemic men and women have been recruited for a monocentric, randomized, double-blind and parallel intervention, 4-week controlled study. Volunteers consumed three experimental products (butter, dessert cream and cookies) made with one of the three specific milk fats (55 g fat per day). During the first week (run-in period), the subjects consumed on a daily basis dairy products containing 72% SFA/2.85% R-TFA (called ‘L0’). For the next 3 weeks of the study (intervention period), the first group continued to consume L0 products. The second group received dairy products containing 63.3% SFA/4.06% R-TFA (called ‘L4’), and the third group received dairy products containing 56.6% SFA/12.16% R-TFA (called ‘L9’).

Results:

Plasma concentrations of high-density lipoprotein (HDL)-cholesterol were not significantly altered by either diet (P=0.38). Compared to L0 diet, L4 diet contributed to reduce low-density lipoprotein (LDL)-cholesterol (−0.14±0.38 mmol/l, P=0.04), total cholesterol (−0.13±0.50 mmol/l, P=0.04), LDL-cholesterol/HDL-cholesterol (−0.14±0.36, P=0.03) and total cholesterol/HDL-cholesterol (−0.18±0.44, P=0.02).

Conclusions:

Different milk fat profiles can change cardiovascular plasma parameters in human healthy volunteers. A limited increase of the R-TFA/SFA ratio in dairy products is associated with an improvement in some cardiovascular risk factors. However, a further increase in R-TFA/SFA ratio has no additional benefit.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Afssa (2005). Risques et bénéfices pour la santé des acides gras trans apportés par les aliments—Health risks and benefits of trans fatty acids in food—Recommendations (synthesis), pp. 1–217. AFSSA, Maison-Alfort.

  • Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC (1999). Trans fatty acids and coronary heart disease. N Engl J Med 340, 1994–1998.

    Article  CAS  Google Scholar 

  • Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H (2003). High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 133, 1186–1191.

    Article  CAS  Google Scholar 

  • Booker CS, Mann JI (2008). Trans fatty acids and cardiovascular health: translation of the evidence base. Nutr Metab Cardiovasc Dis 18, 448–456.

    Article  CAS  Google Scholar 

  • Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL et al. (2008). Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558–566.

    Article  CAS  Google Scholar 

  • Chardigny JM, Malpuech-Brugere C, Dionisi F, Bauman DE, German B, Mensink RP et al. (2006). Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemp Clin Trials 27, 364–373.

    Article  CAS  Google Scholar 

  • Chilliard Y, Ferlay A (2004). Dietary lipids and forages interactions on cow and goat milk fatty acid composition and sensory properties. Reprod Nutr Dev 44, 467–492.

    Article  CAS  Google Scholar 

  • Dalainas I, Ioannou HP (2008). The role of trans fatty acids in atherosclerosis, cardiovascular disease and infant development. Int Angiol 27, 146–156.

    CAS  PubMed  Google Scholar 

  • European Heart Network (2008). European cardiovascular disease statistics. In: Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R et al. (eds), 2008 edn. European Heart Network: Brussels. pp 7–8.

  • Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM (2006). n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, 1526S–1535S.

    Article  CAS  Google Scholar 

  • Gebauer SK, Psota TL, Kris-Etherton PM (2007). The diversity of health effects of individual trans fatty acid isomers. Lipids 42, 787–799.

    Article  CAS  Google Scholar 

  • Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA et al. (1997). Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337, 1491–1499.

    Article  CAS  Google Scholar 

  • Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL (2008). Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 37, 173–182.

    Article  Google Scholar 

  • Katan MB, Zock PL, Mensink RP (1995). Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr 15, 473–493.

    Article  CAS  Google Scholar 

  • Mansour MP, Li D, Sinclair AJ (2001). The occurrence of trans-18:1 isomers in plasma lipids classes in humans. Eur J Clin Nutr 55, 59–64.

    Article  CAS  Google Scholar 

  • Mensink RP, Zock PL, Kester AD, Katan MB (2003). Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.

    Article  CAS  Google Scholar 

  • Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S et al. (2008). Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87, 593–599.

    Article  CAS  Google Scholar 

  • Mozaffarian D, Clarke R (2009). Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63 (Suppl 2), S22–S33.

    Article  CAS  Google Scholar 

  • Poppitt SD, Keogh GF, Mulvey TB, McArdle BH, MacGibbon AK, Cooper GJ (2002). Lipid-lowering effects of a modified butter-fat: a controlled intervention trial in healthy men. Eur J Clin Nutr 56, 64–71.

    Article  CAS  Google Scholar 

  • Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L et al. (2003). Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis 167, 149–158.

    Article  CAS  Google Scholar 

  • Roy A, Ferlay A, Chilliard Y (2006). Production of butter fat rich in trans10-C18:1 for use in biomedical studies in rodents. Reprod Nutr Dev 46, 211–218.

    Article  CAS  Google Scholar 

  • Scientific Panel on Dietetic Products NaA (2004). Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids (Request No EFSA-Q-2003-022). EFSA J 81, 1–49.

    Google Scholar 

  • Seidel C, Deufel T, Jahreis G (2005). Effects of fat-modified dairy products on blood lipids in humans in comparison with other fats. Ann Nutr Metab 49, 42–48.

    Article  CAS  Google Scholar 

  • Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991). A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325, 373–381.

    Article  CAS  Google Scholar 

  • Stender S, Dyerberg J (2003). The influence of trans fatty acids on health. 4th edn. A Report from the Danish Nutrition Council Publication. Danish Nutrition Council: Copenhagen, Denmark. Publication No. 34.

    Google Scholar 

  • Stender S, Dyerberg J (2004). Influence of trans fatty acids on health. Ann Nutr Metab 48, 61–66.

    Article  CAS  Google Scholar 

  • Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM (2006). Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 83, 237–243.

    Article  CAS  Google Scholar 

  • Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E et al. (2006). Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr 83, 744–753.

    Article  CAS  Google Scholar 

  • Vermunt SH, Beaufrere B, Riemersma RA, Sebedio JL, Chardigny JM, Mensink RP (2001). Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study. Br J Nutr 85, 387–392.

    Article  CAS  Google Scholar 

  • Yu S, Derr J, Etherton TD, Kris-Etherton PM (1995). Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. Am J Clin Nutr 61, 1129–1139.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the ‘ANR—Agence Nationale de la Recherche—The French National Research Agency’ under the ‘Programme National de Recherche en Alimentation et nutrition humaine’, Project ‘ANR-05-PNRA-no. 5.E.24’. We are indebted to Professor Yves Boirie, PU-PH, MD, who was the principal investigator. We thank the two co-investigators Ms Laporte and Gérard, Nöelle Mathieu for nursing assistance and Ms Caille and Brandolini who assessed the dietician follow-up and Mr Manlhiot for cooking. We thank Ms Chalancon, Laillet, Rousset and Mrs Giraudet and Rigaudière for their technical assistance. We also thank Yves Chilliard and Pierre Capitan (INRA, F-63122, France) for assistance in the analyses of the milk fatty acids.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-M Chardigny.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malpuech-Brugère, C., Mouriot, J., Boue-Vaysse, C. et al. Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women. Eur J Clin Nutr 64, 752–759 (2010). https://doi.org/10.1038/ejcn.2010.73

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.73

Keywords

This article is cited by

Search

Quick links